34841-11-7

Basic information

• Product Name: METHYL 2-METHOXY-5-NITROBENZOATE
• Synonyms: METHYL 2-METHOXY-5-NITROBENZOATE;METHYL 5-NITRO-O-ANISATE;ASISCHEM D13383;2-METHOXY-5-NITROBENZOIC ACID METHYL ESTER;5-NITRO-O-ANISIC ACID METHYL ESTER;RARECHEM AL BF 0877;methyl 5-nitro-2-methoxybenzoate;2-Methoxy-5-nitrobenzoic Acid Methyl Ester Methyl 5-Nitro-o-anisate 5-Nitro-o-anisic Acid Methyl Ester
• CAS NO: 34841-11-7
• Molecular Formula: C₉H₉NO₅
• Molecular Weight: 211.17
• Product Categories: Aromatic Esters;Acids & Esters;Anisoles, Alkyloxy Compounds & Phenylacetates;Nitro Compounds
• Mol File: 34841-11-7.mol
• Article Data: 34

Chemical Properties

• Melting Point: 99-102°C
• Boiling Point: 350.7 °C at 760 mmHg
• Flash Point: 168.3 °C
• Appearance: /
• Density: 1.294 g/cm³
• Vapor Pressure: 4.3E-05mmHg at 25°C
• Refractive Index: 1.54
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: soluble in Toluene
• CAS DataBase Reference: METHYL 2-METHOXY-5-NITROBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 2-METHOXY-5-NITROBENZOATE(34841-11-7)
• EPA Substance Registry System: METHYL 2-METHOXY-5-NITROBENZOATE(34841-11-7)

Safety Data

• Hazardous Substances Data: 34841-11-7(Hazardous Substances Data)

Usage

General Description

Methyl 2-methoxy-5-nitrobenzoate is an organic compound that falls under the category of esters and aryl nitro compounds. It consists of a benzenoid aromatic ring where two positions are substituted by a nitro group (-NO2) and a methoxy group (-OCH3), and the carboxylic acid hydrogen is replaced by a methyl group (-CH3), forming an ester. Methyl 2-methoxy-5-nitrobenzoate is used mainly in organic synthesis. Its exact physical properties such as melting and boiling points may vary. Proper care and handling are advised when dealing with this substance due to its potential risks and hazards.

InChI:InChI=1/C9H9NO5/c1-14-8-4-3-6(10(12)13)5-7(8)9(11)15-2/h3-5H,1-2H3

Upstream product

• 40751-89-1 2-methoxy-5-nitrobenzoic acid 
• 74-88-4 methyl iodide 
• 2516-96-3 2-chloro-5-nitrobenzoic acid 
• 67-56-1 methanol 
• 96-97-9 5-nitrosalicylic acid 
• 77-78-1 dimethyl sulfate 
• 17302-46-4 methyl 2-hydroxy-5-nitrobenzoate 
• 90763-46-5 2-methoxy-5-nitrobenzoyl chloride 
• 186581-53-3 diazomethane 
• 103412-35-7 1-methoxy-12-norherbertene 
• 606-45-1 2-methoxybenzoic acid methyl ester 

Downstream Products

• 1569982-42-8 N-benzyl-2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)benzamide 
• 1569986-04-4 (4-methoxy-3-methoxycarbonyl-phenyl)-[6-(2-methoxy-phenyl)-pyrimidin-4-yl]-ammonium chloride 
• 1569982-45-1 (2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)phenyl)methanol 
• 1569982-47-3 2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)-N-methylbenzamide 
• 1569982-62-2 2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)-N-(pyridin-4-ylmethyl)benzamide 
• 1569982-66-6 2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)benzaldehyde 
• 1569982-68-8 methyl 2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)benzoate 
• 1569982-75-7 N-(3-((benzylamino)methyl)-4-methoxyphenyl)-6-(2-methoxyphenyl)pyrimidin-4-amine hydrochloride 
• 1569982-78-0 2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)benzohydrazide 
• 1569982-81-5 N-(4-methoxy-3-((phenylamino)methyl)phenyl)-6-(2-methoxyphenyl)pyrimidin-4-amine 
• 1569986-42-0 (3-chloromethyl-4-methoxy-phenyl)-[6-(2-methoxy-phenyl)-pyrimidin-4-yl]-ammonium chloride 
• 1569982-85-9 N-(3-((dimethylamino)methyl)-4-methoxyphenyl)-6-(2-methoxyphenyl)pyrimidin-4-amine 
• 1569983-10-3 2-(2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)benzyl)isoindoline-1,3-dione 
• 1569983-17-0 N-(3-(aminomethyl)-4-methoxyphenyl)-6-(2-methoxyphenyl)pyrimidin-4-amine 

Relevant articles and documents

-

-

Aromatic β-sheet foldamers based on tertiary squaramides

The preference of N,N-aryl, alkyl tertiary amides for cis conformations has been exploited through the use of tertiary squaramides as hairpin turn units that promote the folding of aromatic β-sheets. Head-to-head aromatic arrangements were shown to prevail in sufficiently long bent aromatic sequences.

NOVEL COMPOUNDS FOR USE IN CANCER

It relates to the compounds of formula (I), or their pharmaceutically or veterinary acceptable salts, or their stereoisomers or mixtures of stereoisomers, wherein X, L,R1, R 2, and R 3 are as defined herein, which are cancer cell differentiation inducing agents. It also relates to pharmaceutical or veterinary compositions containing them, and to their use in medicine, in particular in the treatment and/or prevention of cancer, in particular by cell differentiation therapy.